
|
Inverness Medical Innovations, Inc.. The Group's principal activities are to develop, manufacture and market in vitro diagnostic products for the over-the-counter pregnancy and fertility/ovulation test market and the professional rapid diagnostic test market. It operates through three segments. Consumer Diagnostic Products segment products targeting ... More
|
|
|
|
First Call expects 0.68 EPS for next quarter.
The current Price Target for IMA is $49.55.

| 42.19 Last |
---- Today’s Change |
-- Today’s Open |
-- Day High |
-- Day Low |
-- Volume |
| Quotes delayed by at least 20 minutes | |||||
IMA
IndustryMouse over chart for more details